Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - CASH & EQUIVALENTS
Cash & Equivalents ENTA - Enanta Pharmaceuticals, Inc.
37.2 M
LAST VALUE
-8.00%
2 YEAR CAGR
-6.18%
5 YEAR CAGR
1.95%
10 YEAR CAGR